Enalare Therapeutics Selected to Present at Three Upcoming Scientific Conferences Regarding Its Lead

PRINCETON, N.J., August 22, 2023 (Newswire.com) - Enalare Therapeutics Inc., a clinical stage biopharmaceutical company dedicated to developing novel compounds for the treatment of life- threatening critical care diseases and community health emergencies, announced today t...

Related Keywords

United States ,California ,San Francisco ,American ,Albert Dahan ,Las Vegas ,Morgan Wagner ,Josephv Pergolizzi ,American Society For Enhanced Recovery ,American Society Of Anesthesiologists ,Enalare Therapeutics Inc ,Head Of Research Development At Enalare ,American Society Of Anesthesiologists Annual Meeting ,Nashville Marriott At Vanderbilt University ,Therapeutics Inc ,American Society ,Enhanced Recovery ,Perioperative Medicine ,Bk Channel Blocker ,Hypoxic Ventilatory Response ,Pharmacologically Induced Respiratory ,Novel Respiratory ,Agnostic Pharmacologic Approach ,Respiratory Depression ,Nashville Marriott ,Vanderbilt University ,Channel Blocker ,Increases Hypoxic Ventilatory Sensitivity ,Mitigates Propofol Induced Respiratory Effects ,Anesthesiologists Annual ,Anesthesiology Annual Meeting ,Contact Information ,Enalare Therapeutics Selected ,